Naproxen Sodium
NDC Package 62037-826-75
Package Information
Naproxen Sodium is see also Warning section. Marketed by Actavis Pharma, Inc., this product is identified by NDC 62037-826 and is authorized under FDA application ANDA075416.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 62037 - Actavis Pharma, Inc.
- 62037-826 - Naproxen Sodium
- 62037-826-75 - 75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE
- 62037-826 - Naproxen Sodium
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 62037-826-75 identifies a specific commercial package of 75 tablet, film coated, extended release in 1 bottle of Naproxen Sodium, labeled by Actavis Pharma, Inc.. This is formulated for use and contains as the active substance.
Is this product currently listed with the FDA?
This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Actavis Pharma, Inc. on September 30, 2014. The current certification is valid through August 31, 2019.
What are the primary indications for this medication?
See also Warning section. Naproxen is used to relieve pain from various conditions such as headache, muscle aches, tendonitis, dental pain, and menstrual cramps. It also reduces pain, swelling, and joint stiffness caused by arthritis, bursitis, and gout attacks. This medication is known as a nonsteroidal anti-inflammatory drug (NSAID). It works by blocking your body's production of certain natural substances that cause inflammation. If you are treating a chronic condition such as arthritis, ask your doctor about non-drug treatments and/or using other medications to treat your pain. Check the ingredients on the label even if you have used the product before. The manufacturer may have changed the ingredients. Also, products with similar names may contain different ingredients meant for different purposes. Taking the wrong product could harm you.
How is this Actavis Pharma, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 62037082675. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 75 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.